VTN

vitronectin

Summary

The protein encoded by this gene functions in part as an adhesive glycoprotein. Differential expression of this protein can promote either cell adhesion or migration as it links cells to the extracellular matrix through a variety of ligands. These ligands include integrins, plasminogen activator inhibitor-1, and urokinase plasminogen activator receptor. This secreted protein can be present in the plasma as a monomer or dimer and forms a multimer in the extracellular matrix of several tissues. This protein also inhibits the membrane-damaging effect of the terminal cytolytic complement pathway and binds to several serpin serine protease inhibitors. This protein can also promote extracellular matrix degradation and thus plays a role in tumorigenesis. It is involved in a variety of other biological processes such as the regulation of the coagulation pathway, wound healing, and tissue remodeling. The heparin-binding domain of this protein give it anti-microbial properties. It is also a lipid binding protein that forms a principal component of high density lipoprotein. [provided by RefSeq, Aug 2020]

Known Variants59 total

rsidPosition (GRCh37)AllelesClassClinVar
rs15024133517:26,694,432G/A—likely benign
rs99407137717:26,694,445T/C—uncertain significance
rs250815083717:26,694,452G/A—uncertain significance
rs78189069117:26,694,461T/C—likely benign
rs175577205217:26,694,476T/A—uncertain significance
rs222772817:26,694,483A/G—benign
rs321134417:26,694,746G/T—uncertain significance
rs11170776817:26,694,793C/T—uncertain significance
rs250815208417:26,694,798C/T—uncertain significance
rs70417:26,694,861G/A—benign
rs155558324817:26,694,864G/A—uncertain significance
rs78247669017:26,694,865C/T—uncertain significance
rs36899168217:26,694,877G/A—uncertain significance
rs91665717:26,694,890G/A—benign
rs15056608317:26,694,894C/T—uncertain significance
rs13955357617:26,694,903C/T—uncertain significance
rs90294233617:26,694,979G/C—uncertain significance
rs78279716317:26,695,010C/A—uncertain significance
rs250815334517:26,695,038C/T—uncertain significance
rs37423191717:26,695,040G/A—likely benign
rs78248470017:26,695,044C/G—uncertain significance
rs55413638017:26,695,051G/A—uncertain significance
rs37764733117:26,695,054T/C—uncertain significance
rs78230687817:26,695,084T/C—likely benign
rs14265199417:26,695,549T/A—uncertain significance
rs14338014217:26,695,573G/C—uncertain significance
rs52792777617:26,695,625G/A—uncertain significance
rs3413492917:26,695,630G/A—benign
rs250815548817:26,695,689G/C—uncertain significance
rs222772517:26,695,704A/G—benign
rs78237555617:26,695,896T/G—uncertain significance
rs222772317:26,695,916C/T—benign
rs56445901217:26,695,917G/C—uncertain significance
rs146765743517:26,695,923T/A—uncertain significance
rs78226863217:26,696,033C/T—uncertain significance
rs78197884917:26,696,043G/C—uncertain significance
rs250815770417:26,696,338T/A—uncertain significance
rs78235668217:26,696,345G/A—uncertain significance
rs20187175617:26,696,354C/T—uncertain significance
rs37198223817:26,696,379C/G—uncertain significance
rs78236975517:26,696,444A/G—uncertain significance
rs3533910017:26,696,550G/A—benign
rs104429665417:26,696,563G/T—uncertain significance
rs78282053017:26,696,570C/T—uncertain significance
rs37365019817:26,696,571G/A—likely benign
rs78222221317:26,696,613C/T—likely benign
rs11288730017:26,696,680T/A—conflicting classifications of pathogenicity
rs14409334817:26,696,686G/A—uncertain significance
rs250815934817:26,696,764A/G—likely benign
rs36775651017:26,696,768A/G—uncertain significance
rs14509519417:26,696,866C/T—uncertain significance
rs78202268817:26,696,877A/G—likely benign
rs14024841717:26,696,988C/G—uncertain significance
rs11149065317:26,697,009G/A—benign
rs14586174517:26,697,033G/A—likely benign
rs37656438817:26,697,152C/A—likely benign
rs14899400517:26,697,164G/C—uncertain significance
rs222772117:26,697,451C/Aregulatory region variant—
rs222772017:26,697,521A/Gregulatory region variant—

Gene information from NCBI Gene. Variant classifications from ClinVar.